Incidence of Kaposi sarcoma in HIV-infected patients receiving antiretroviral therapy: A prospective multicohort study from southern Africa.

Julia Bohlius(University of Bern), Fabio Valeri(Institute of Social and Preventive Medicine), Thomas Gsponer(University of Bern), Cleophas Chimbetete, Hans Prozesky(Stellenbosch University), Priscilla Lumano‐Mulenga(Ministry of Health), Mhairi Maskew(University of the Witwatersrand), Margot Egger
Journal of Clinical Oncology
May 20, 2011
10.1200/jco.2011.29.15_suppl.1589
Cited by 0

Related Papers

Erythropoietin or darbepoetin for patients with cancer
|Cochrane Database of Systematic Reviews|2012|388
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
|AIDS|2014|375
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis
|JNCI Journal of the National Cancer Institute|2007|366
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
|The Lancet HIV|2021|180
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
|Blood Advances|2019|165